In the News

Morning Consult
Under the leadership of Centers for Medicare and Medicaid Services Administrator Seema Verma, the Trump administration recently released key guidance mitigating pharmacy benefit managers’ abusive “spread pricing” practices in state Medicaid-managed care programs…Read More.

McKnight’s LTC News
As Congress and the Trump Administration advance sweeping prescription drug price reforms, it is essential to recognize independent long-term care pharmacies…Read More.

Morning Consult
Pharmacy benefit managers are the latest industry group set to appear before the Senate Finance Committee to detail their role in the drug pricing supply chain and offer ideas to lower prescription drug prices…Read More.

RE: CMS Proposed Rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, CMS 4180-P, RIN 0938-AT92, 83 Fed. Reg. 62152…Read More.

Consumer Affairs
One group worries about what it will mean for seniors…Read More.

Healthcare Finance
The proposed CVS Health-Aetna merger is emblematic of the growing arms race to consolidate and control consumer access to appropriate prescription drugs, particularly LTC (long-term care) patients…Read More.

The Hill
When it comes to the “alphabet soup” of federal agencies, one’s eyes can glaze over in confusion and uncertainty about what they do, why they do it, and how average citizens benefit from their federally-funded oversight…Read More.

Health Economics
Pharmacy benefit managers have long enough taken advantage seniors and taxpayers in the U.S. through strategies that exploit Medicare, Senior Care Pharmacy Coalition President/CEO Alan Rosenbloom writes…Read More.

McKnight’s
As much as we can appreciate the ingenuity of entrepreneurs in a free market, programs like Medicare were never intended to pad the pockets of businesses at the expense of consumers and taxpayers…Read More.